Akebia Therapeutics Inc (AKBA)
1.86
-0.06
(-3.12%)
USD |
NASDAQ |
Nov 14, 16:00
1.865
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Cash from Investing (Quarterly): -0.002M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.002M |
| June 30, 2024 | -0.029M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.114M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 20.00M |
| March 31, 2021 | 19.94M |
| December 31, 2020 | 59.68M |
| September 30, 2020 | -49.94M |
| June 30, 2020 | -50.00M |
| March 31, 2020 | 0.245M |
| December 31, 2019 | 22.28M |
| September 30, 2019 | 24.39M |
| June 30, 2019 | 54.03M |
| March 31, 2019 | 110.47M |
| December 31, 2018 | 16.72M |
| Date | Value |
|---|---|
| September 30, 2018 | 11.01M |
| June 30, 2018 | -3.568M |
| March 31, 2018 | 12.43M |
| December 31, 2017 | -8.308M |
| September 30, 2017 | -44.96M |
| June 30, 2017 | -31.69M |
| March 31, 2017 | -92.30M |
| December 31, 2016 | 22.31M |
| September 30, 2016 | 45.57M |
| June 30, 2016 | 29.79M |
| March 31, 2016 | -84.96M |
| December 31, 2015 | 1.638M |
| September 30, 2015 | -14.46M |
| June 30, 2015 | -4.276M |
| March 31, 2015 | 3.405M |
| December 31, 2014 | -7.637M |
| September 30, 2014 | -40.00M |
| June 30, 2014 | -23.08M |
| March 31, 2014 | 5.358M |
| December 31, 2013 | 1.735M |
| September 30, 2013 | -13.16M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-50.00M
Minimum
Jun 2020
59.68M
Maximum
Dec 2020
1.104M
Average
--
Median
Sep 2021
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics Inc | -44.04M |
| Bioventus Inc | -0.064M |
| Eli Lilly and Co | -4.005B |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | -0.0049M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.695M |
| Cash from Financing (Quarterly) | 1.223M |
| Free Cash Flow | -38.53M |
| Free Cash Flow Per Share (Quarterly) | -0.0318 |
| Free Cash Flow to Equity (Quarterly) | -7.021M |
| Free Cash Flow Yield | -10.17% |